May 6th, 2026
Novo Raises Forecast as Wegovy Pill Fuels Sales
Novo Nordisk said this year’s declines won’t be as bad as initially expected thanks to the new Wegovy pill, which helped fuel sales in the first quarter. For the year, the worst drop for both profit and sales will be 12%, compared with 13% earlier. Bloomberg's Sanne Wass reports from Copenhagen.
